Form 4: Biogen Executive Priya Singhal Reports Stock Transactions

Priya Singhal, Head of Development at Biogen, reports acquisition and disposal of common stock and restricted stock units.

Summary

• Priya Singhal, Head of Development at Biogen, filed a Form 4 detailing changes in beneficial ownership.
• On February 7, 2025, Singhal acquired 2,216 shares of common stock upon the vesting of restricted stock units.
• Also on February 7, 2025, Singhal disposed of 681 shares of common stock to cover tax obligations at a price of $141.35 per share.
• Following these transactions, Singhal directly owns 8,211.4761 shares of common stock.
• Singhal also holds 4,434 restricted stock units after the reported transactions.
• On February 6, 2025, Singhal was granted 14,050 restricted stock units which vest in three equal yearly installments beginning on February 6, 2025.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the actions of company executives and their holdings in the company's stock.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they represent a small portion of the overall outstanding shares.

Key Dates

Keywords

Form 4, Beneficial Ownership, Biogen, BIIB, Priya Singhal, Restricted Stock Units, Common Stock, Insider Trading